112 related articles for article (PubMed ID: 15788661)
1. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
2. The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis.
Jung SP; Kim S; Nam SJ; Kim I; Bae JW
J Breast Cancer; 2013 Mar; 16(1):16-22. PubMed ID: 23593077
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Frequently Down-Regulated Phosphatidylethanolamine-Binding Protein-1 in Gallbladder Cancer.
Bharti A; Ansari MA; Tewari M; Narayan G; Singh S
Dig Dis Sci; 2024 Feb; 69(2):502-509. PubMed ID: 38135812
[TBL] [Abstract][Full Text] [Related]
4. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.
González-Martínez S; Kajabova VH; Pérez-Mies B; Carretero-Barrio I; Caniego-Casas T; Sarrió D; Moreno-Bueno G; Gión M; Perez-García J; Cortés J; Smolkova B; Palacios J
Virchows Arch; 2024 May; ():. PubMed ID: 38713384
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer.
Bao-Caamano A; Costa-Fraga N; Cayrefourcq L; Jácome MA; Rodriguez-Casanova A; Muinelo-Romay L; López-López R; Alix-Panabières C; Díaz-Lagares A
Sci Rep; 2023 Sep; 13(1):15401. PubMed ID: 37717096
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Breast Cancer: An Old Story with a New End.
Neves Rebello Alves L; Dummer Meira D; Poppe Merigueti L; Correia Casotti M; do Prado Ventorim D; Ferreira Figueiredo Almeida J; Pereira de Sousa V; Cindra Sant'Ana M; Gonçalves Coutinho da Cruz R; Santos Louro L; Mendonça Santana G; Erik Santos Louro T; Evangelista Salazar R; Ribeiro Campos da Silva D; Stefani Siqueira Zetum A; Silva Dos Reis Trabach R; Imbroisi Valle Errera F; de Paula F; de Vargas Wolfgramm Dos Santos E; Fagundes de Carvalho E; Drumond Louro I
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510269
[TBL] [Abstract][Full Text] [Related]
7. An Optimized CoBRA Method for the Microfluidic Electrophoresis Detection of Breast Cancer Associated
Aibel C; Coll De Peña A; Tripathi A
BioTech (Basel); 2023 Jan; 12(1):. PubMed ID: 36648833
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer.
Luo J; Chen S; Chen J; Zhou Y; He F; Wang E
PLoS One; 2022; 17(12):e0278270. PubMed ID: 36454866
[TBL] [Abstract][Full Text] [Related]
9.
Bücker L; Lehmann U
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139537
[TBL] [Abstract][Full Text] [Related]
10. Recognizing Tumor Origin for Lymphoid Tumor of Unknown Primary
Lu W; Qiu J; Xie X; Li K; Duan Y; Li M; Ma C; Cheng Z; Liu S
Front Oncol; 2022; 12():766490. PubMed ID: 35186725
[TBL] [Abstract][Full Text] [Related]
11. Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma.
Lin SY; Zhang A; Lian J; Wang J; Chang TT; Lin YJ; Song W; Su YH
Cells; 2021 May; 10(6):. PubMed ID: 34071075
[TBL] [Abstract][Full Text] [Related]
12. Differentiating the lymph node metastasis of breast cancer through dynamic contrast-enhanced magnetic resonance imaging.
Dong X; Chunrong Y; Hongjun H; Xuexi Z
BJR Open; 2019; 1(1):20180023. PubMed ID: 33178917
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin deregulation in breast cancer.
Corso G; Figueiredo J; De Angelis SP; Corso F; Girardi A; Pereira J; Seruca R; Bonanni B; Carneiro P; Pravettoni G; Guerini Rocco E; Veronesi P; Montagna G; Sacchini V; Gandini S
J Cell Mol Med; 2020 Jun; 24(11):5930-5936. PubMed ID: 32301282
[TBL] [Abstract][Full Text] [Related]
14. Promoter Methylation Status of the Retinoic Acid Receptor-Beta 2 Gene in Breast Cancer Patients: A Case Control Study and Systematic Review.
Yari K; Rahimi Z
Breast Care (Basel); 2019 Apr; 14(2):117-123. PubMed ID: 31798384
[TBL] [Abstract][Full Text] [Related]
15. Value of contrast-enhanced ultrasound combined with elastography in evaluating cervical lymph node metastasis in papillary thyroid carcinoma.
Jiang W; Wei HY; Zhang HY; Zhuo QL
World J Clin Cases; 2019 Jan; 7(1):49-57. PubMed ID: 30637252
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women.
Nunes SP; Moreira-Barbosa C; Salta S; Palma de Sousa S; Pousa I; Oliveira J; Soares M; Rego L; Dias T; Rodrigues J; Antunes L; Henrique R; Jerónimo C
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30261643
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum-Implications for the Choice of Circulating Tumour DNA Methylation Markers.
Le AV; Szaumkessel M; Tan TZ; Thiery JP; Thompson EW; Dobrovic A
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154364
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.
Thomas ML; Marcato P
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29614786
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.
Abdel-Hafiz HA
Diseases; 2017 Jul; 5(3):. PubMed ID: 28933369
[TBL] [Abstract][Full Text] [Related]
20. Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.
Deshmukh SK; Srivastava SK; Tyagi N; Ahmad A; Singh AP; Ghadhban AAL; Dyess DL; Carter JE; Dugger K; Singh S
Carcinogenesis; 2017 Aug; 38(8):757-765. PubMed ID: 28430867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
